Coalition Pledges $16m for Brain Cancer Trials
The Victorian Coalition has committed $16 million to expand brain cancer clinical trials through the BrainPOP program in Melbourne.
Updated on Nov. 19, 2026 in Cancer

The Victorian Coalition has pledged $16 million to fund brain cancer clinical trials run through the Brain Perioperative Program (BrainPOP). The funding would be directed to BrainPOP over four years, which links hospitals and laboratories across Melbourne's Parkville biomedical precinct.
Why it matters
About 76 per cent of brain cancer patients die within five years of diagnosis, and the expansion would give newly diagnosed Victorians access to novel diagnostic testing tailored to each individual. The pledge would also expand clinical trials and attract leading international research to the state.
The $16 million pledge is set against a survival picture in which about 76 per cent of brain cancer patients die within five years of diagnosis. The source does not state when the funding would be released or when new trial participants could start enrolling.
The players
Jess Wilson
Jess Wilson is a Victorian Liberal politician and leader of the Victorian Coalition, who made the funding pledge.
Georgie Crozier
Georgie Crozier is a Victorian Nationals politician who is part of the Coalition's public policy announcements.
The details
BrainPOP, established four years ago through The Brain Cancer Centre, is currently testing a series of new therapies and enables researchers to test treatments directly in the brain. The Coalition's pledge would direct $16 million to the program over four years to expand these clinical trials.
Timeline
Four years ago: BrainPOP was established through The Brain Cancer Centre.
Over the next four years: the Coalition's $16 million would flow into BrainPOP.
Health Landscape
The pledge follows an earlier $16 million Victorian government investment in BrainPOP, matching that amount to extend the program's trial work. It places brain cancer clinical research within an ongoing state-level effort to bring novel diagnostic testing to Victorian patients.
Newly diagnosed Victorian brain cancer patients could gain access to novel diagnostic testing tailored to each individual if the BrainPOP expansion proceeds. The source does not indicate when such testing would become available to patients.
The takeaway
State funding for trials that test therapies directly in the brain could widen access to newer treatments for patients facing a diagnosis with high mortality. Patients and families should ask their treating teams whether trials such as BrainPOP are an option.
Further reading
Explore more on Cancer research and treatment developments across Victoria.
Source note: This article includes information reported by Herald Sun.






